Data / Form D filings / Nutrivert Inc.
Nutrivert Inc.: Form D filings
Nutrivert Inc., a pharmaceuticals company in Atlanta, GA, filed 2 Form D notices with the SEC between 2023 and 2026. The latest, on April 29, 2026, reports $2.4 million sold of a $6 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2525 PEACHTREE ROAD NE #27, Atlanta, GA, 30305
- Phone
- (404) 680-1486
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1970591
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | New notice | $5,999,989 | $2,374,992 | $3,624,997 | 2 | Apr 10, 2026 | sec.gov |
| Mar 23, 2023 | New notice | $2,000,000 | $1,500,274 | $499,726 | 1 | Mar 8, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Horace Nalle | Executive Officer, Director | |
| Bernhard Kaltenboeck | Executive Officer, Director | |
| Peter Selover | Executive Officer, Director | |
| Troy Merry | Director |
Other pharmaceuticals companies in Georgia that filed recently
- Laurentide Therapeutics Inc. $99,999 · Sep 28, 2026
- LifeCyte Innovations, Inc. $1 million · Aug 20, 2026
Every Form D from the week of Apr 27, 2026 · All recent filings in Georgia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Nutrivert Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.